Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01851772 · ClinicalTrials.gov registry record · NA

Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer

A NA study, sponsored by Xoft.

Completed
Registry status
NA
Development phase
3
Enrollment target

NCT01851772: Completed NA study, sponsored by Xoft.

NCT01851772 is a NA study that has completed, run by Xoft. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01851772, a NA study, has completed, sponsored by Xoft.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety, performance and usability of the Xoft Axxent Electronic Brachytherapy System and Cervical Applicator as incorporated into the physician's current standard treatment practice and in replacement of high-dose-rate after-loaders using Iridium-192 or low-dose-rate Cesium treatments. Data will be collected on treatment delivery, safety, and acute toxicity. Our hypothesis is that the treatment is safe as incorporated into the physician's current standard of practice.

Primary Outcome

Adverse event rate and severity during and following the administration of brachytherapy treatment, through discharge from the treatment facility, and for 3 months after treatment.

Interventions

  • DEVICE Treatment with Electronic Brachytherapy

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2013-11
Est. Completion 2015-06
Phase NA
Xoft

10 total trials

What the finished NCT01851772 record still lists

NCT01851772 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Treatment with Electronic Brachytherapy is the first listed.

NCT01851772 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01851772 about?

NCT01851772 is a clinical study titled "Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer". The purpose of this study is to evaluate the safety, performance and usability of the Xoft Axxent Electronic Brachytherapy System and Cervical Applicator as incorporated into the physician's current standard treatment practice and in replacement of high-dose-rate after-loaders using Iridium-192 or l...

What is the current status of trial NCT01851772?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2013-11. Estimated completion is 2015-06.

What interventions are being tested in trial NCT01851772?

The interventions under investigation include: Treatment with Electronic Brachytherapy (DEVICE).

Who is sponsoring clinical trial NCT01851772?

This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01851772's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01851772, the US trial registry maintained by the National Library of Medicine. NCT01851772 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.